Circulating FABP4 Is a Prognostic Biomarker in Patients With Acute Coronary Syndrome but Not in Asymptomatic IndividualsSignificance
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.115.305365
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)